Del 166 - Advances in Immunology
Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B
Inbunden, Engelska, 2025
2 709 kr
Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding and respected serial on the subject matter
- Focuses on recent advances in the field of immunology
Produktinformation
- Utgivningsdatum2025-08-15
- Mått152 x 229 x undefined mm
- Vikt450 g
- FormatInbunden
- SpråkEngelska
- SerieDel 166 i Advances in Immunology
- Antal sidor272
- FörlagElsevier Science
- ISBN9780443317484
Kenneth M. Murphy works in Washington University School of Medecine, USA. Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School. Dr. Arun Kumar Singh is an assistant professor in the Department of Pharmacy at Vivekanand Global University, Jaipur. He completed both his MPharm in Pharmaceutics and his PhD at Galgotias University, Greater Noida. His research strengths lie in AI-driven cancer research, nano-formulation, and the intersection of blockchain, IoT, machine learning, big data, and neuroscience with pharmaceutical science. He has authored books and contributed chapters on big data and cancer, and his work includes reviews published in reputable journals. His research appears across publishers such as IOP, Elsevier, CRC Press, and Wiley, reflecting a broad publication record and ongoing contributions to AI-enabled oncology and advanced drug delivery. Dr. Neeraj Mishra is a Professor at the Amity Institute of Pharmacy, Gwalior, where he has served since July 2019. He has over 20 years of teaching and research experience and more than 150 international and national publications in novel, localized, targeted, and controlled drug delivery systems, including nano- and microparticles for the treatment of breast and colon cancer and neurodegenerative disorders. Dr. Mishra has authored 25 books and 45 book chapters with leading publishers such as Elsevier, Bentham, Springer, and Wiley, and holds five patents (three international and two Indian). His honors include the Distinguished Professor Awards (2019, 2021), Outstanding Scientist Award (2020), and Best Academician Award (2023). In 2025, he was recognized as one of the World’s Top 2% Scientists by Stanford University and Elsevier. Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Dr. Prabhakar is a Professor and Head in the Department of Biotechnology at Nagaland University, Kohima, India. He has been recognized among leading global scientists by Stanford’s annual Top Scientists list. He earned his PhD in Biotechnology from IIT Madras. His research centers on molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society, and contributes as an editorial board member and reviewer for multiple journals. Dr. Prabhakar has received honors including a travel grant to a European conference supported by IIT Madras and CSIR, and funding approved by the Department of Science and Technology. He has published a substantial body of work, authored or edited several books, contributed many chapters, and given numerous talks and poster presentations at conferences.
- 1. Harnessing the immune system: Insights into cancer vaccines Sushree Subhadra Acharya, Subhasmita Bhal, Biswajit Das, and Chanakya Nath Kundu 2. Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, Soyal Sayyed, Amulya Jindal, Pankaj Kumar, Abhijeet Chinchane, Atreyee Bhattacharyya, Roshani Jaiswal, Sagar Kulkarni, Shubham Gajdhane, Jitender Madan, and Abhay Asthana 3. Nanoparticles for mRNA-based cancer immunotherapy Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, and Neeraj Mishra 4. B-cell editing: An emerging alternative of precision oncotherapy Pritha Roy Choudhury, Mohona Chakravarti, Saptak Banerjee, Rathindranath Baral, and Anamika Bose 5. Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy Krishnendu Adhikary, Abhik Paul, Ayush Madan, Anas Islam, Sumel Ashique, and Mohhammad Ramzan 6. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development Anas Islam, Vijay Singh, Pooja S. Murkute, Sumel Ashique, Shriyansh Srivastava, Mohammad Yousuf Ansari, and Sabina Yasmin 7. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy Monika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, Vijayaraj Surendran, Sumel Ashique, Anas Islam, Naheed Mojgani, and Afzal Hussain
Du kanske också är intresserad av
Advances in Immunology
Frederick W. Alt, Kenneth Murphy, USA) Alt, Frederick W. (Investigator and Director, Program in Cellular and Molecular Medicine, Howard Hughes Medical Institute Research Laboratories, The Children's Hospital, Boston, MA, USA) Murphy, Kenneth (Washington University School of Medecine
2 709 kr
Advances in Immunology
Frederick W. Alt, Kenneth Murphy, USA) Alt, Frederick W. (Investigator and Director, Program in Cellular and Molecular Medicine, Howard Hughes Medical Institute Research Laboratories, The Children's Hospital, Boston, MA, USA) Murphy, Kenneth (Washington University School of Medecine, Kenneth M. Murphy
2 709 kr
Advances in Immunology
Frederick W. Alt, Kenneth Murphy, USA) Alt, Frederick W. (Investigator and Director, Program in Cellular and Molecular Medicine, Howard Hughes Medical Institute Research Laboratories, The Children's Hospital, Boston, MA, USA) Murphy, Kenneth (Washington University School of Medecine, Kenneth M. Murphy
2 709 kr